Symptom assessment and management

Neurologic Clinics

Volumn 19, Issue 4, 2001, Pages 921-947

  Carver, Alan C ^a,b   Foley, Kathleen M ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; DYSPNEA; FUNCTIONAL ASSESSMENT; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; NAUSEA; NEUROLOGIC DISEASE; NEUROLOGY; PAIN; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TREATMENT PLANNING; VALIDATION PROCESS; VOMITING;

EID: 0035171639     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(05)70054-2     Document Type: Article

References (97)

1. The TTS-Fentanyl Cooperative Trial Group: Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life
2. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial
3. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial
4. The neurologist and the dying patient
5. Slow euthanasia
6. Pain, opioid use and survival in hospitalized patients with advanced cancer
7. Treating sickle cell pain like cancer pain
8. Randomized, double-blinded, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain
9. Role of methadone in the management of pain in cancer patients
10. Opioid rotation in patients with cancer pain: A retrospective comparison of dose rations between methadone, hydromorphone, and morphine
11. The Supreme Court speaks: Not assisted suicide but a constitutional right to palliative care
12. Management of cancer pain
13. End of life care: A survey of US neurologists' attitudes, behavior, and knowledge
14. Sedation for intractable distress in the dying: A survey of experts
15. Opioid pharmacotherapy in the management of cancer pain
16. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: A combined analysis of controlled, single-dose studies
17. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain
18. Patient controlled analgesia for severe cancer pain
19. Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)
20. Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life
21. Potentiation of opioid analgesia by psychostimulant drugs: A review
22. The use of transdermal scopolamine in the control of death rattle
23. Randomised double-blind, active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain
24. Barriers to better pain control in hospitalized patients
25. Management of dyspnea and cough in patients with cancer
26. Implementation of guidelines for cancer pain management: Results of a randomized controlled clinical trial
27. Use of corticosteroids in the treatment of symptoms associated with cancer
28. COX-2-specific inhibitors - The emergence of a new class of analgesic and anti-inflammatory drugs
29. Oral transmucosal fentanyl citrate: Randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients
30. The Memorial Pain Assessment Card: A valid instrument for the evaluation of cancer pain
31. Changing concepts of tolerance to opioids: What the cancer patient has taught us
32. Methadone in cancer pain management: Individualize dose and titrate to effect
33. Perspectives on the medical use of drugs of abuse
34. Pain medicine education among American neurologists: A need for improvement
35. The impact of a comprehensive evaluation in the management of cancer pain
36. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl D-aspartate (NMDA) receptor in rat forebrain and spinal cord
37. The measurement of pain and other symptoms
38. Symptom assessment
39. Management of cancer pain: Adults quick reference guide
40. The WHO analgesic ladder for cancer pain management: Stepping up the quality of its evaluation
41. Midazolam in terminal care
42. The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: Application in bone metastases and the opioid bowel syndrome
43. Central nervous system excitatory effects of meperidine in cancer patients
44. Pain management in osteoarthritis: The role of Cox-2 inhibitors
45. Strategies for limiting the side effects of cancer pain therapy
46. Methylphenidate in terminal depression
47. Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: Clinical observations
48. Inappropriate use of naloxone in cancer patients with pain
49. Palliation of nausea and vomiting
50. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
51. The McGill pain questionnaire: Major properties and scoring methods
52. The role of morphine glucuronides in cancer pain
53. The role of octreotide in palliative care
54. Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home
55. Octreotide may prevent definitive intestinial obstruction
56. Classification of chronic pain: Description of chronic pain syndromes and definitions of pain terms
57. Morphine drips, terminal sedation, and slow euthanasia: Definitions and facts, not anecdotes
58. Pharmacological characterization of morphine-6-glucuronide: A very potent morphine metabolite
59. Quality of life and cancer pain: Satisfaction and side effects with transdermal fentanyl versus oral morphine
60. Venlafaxine for the treatment of neuropathic pain
61. Management of pain during debridement: A survey of U.S. burn units
62. Morphine infusions at the end of life: The pitfalls in reasoning from anecdote
63. Constipation in the cancer patient: Causes and management
64. Chronic use of opioid analgesics in nonmalignant pain: Report of 38 cases
65. Breakthrough pain: Definition, prevalence, and characteristics
66. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: A controlled dose titration study
67. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics, and distress
68. Addiction rare in patients treated with narcotics
69. Practice parameter: The care of the patient with amyotrophic lateral sclerosis
70. Management of bowel obstruction in advanced cancer patients
71. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio?
72. An update on the clinical use of methadone for cancer pain
73. Lidocaine patch: Double-blind controlled study of a new treatment method for post-herpetic neuralgia
74. Gabapentin for the treatment of post-herpetic neuralgia: A randomized controlled trial
75. Is post-herpetic neuralgia more than one disorder?
76. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms
77. Decisions near the end of life: Professional views of life-sustaining treatments
78. The use and abuse of the principle of double effect
79. A controlled trial to improve care for seriously ill hospitalized patients: The study to understand prognosis and preferences for outcomes and risks of treatments
80. Barbiturates in the care of the terminally ill
81. Symptom prevalence and control during cancer patients' last days of life
82. A validation study of the WHO methods for cancer pain relief
83. Physician attitudes and practice in cancer pain management: A survey from the Eastern Cooperative Oncology Group
84. Corticosteroids as adjuvant analgesics
85. Antidepressant drugs as adjuvant analgesics
86. Eficacy of oxycodone in neuropathic pain: A randomized trial in post-herpetic neuralgia
87. Opioid pseudoaddiction: An iatrogenic syndrome
88. Ordering and administration of sedatives and analgesics during the withholding and withdrawal of life support from critically ill patients
89. Corticosteroids in advanced cancer
90. Validation of WHO guidelines for cancer pain relief: A 10-year prospective study
91. Long-term oral opioid therapy in patients with chronic nonmalignant pain